2m 2m 2m 2m 2m 2m 2m
BRIACELL THERAP (BCTX)
NASDAQ
$3.41-$0.10 (-2.88%)
Price as of Nov 13, 2026 12:48 PM EST- $30.7MMarket Cap
- -63.96%1-Year Change
- BiotechnologyIndustry
BRIACELL THERAP (BCTX)
$3.41-$0.10 (-2.88%)
BCTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.51 | ||
Change | -$0.08 (-2.23%) | ||
Open | $3.59 | ||
High | $3.65 | ||
Low | $3.39 | ||
Previous Close | $3.59 | ||
Volume | 44,784 | ||
30-Day Average Volume | 64,847 | ||
1-Week Change | 7.34% | ||
1-Month Change | -9.30% | ||
1-Year Change | -63.96% | ||
3-Year Change | -99.41% | ||
5-Year Change | -99.77% | ||
Fundamentals | |||
Shares Outstanding | 8.7M | ||
Total Assets | $23.6M | ||
Market Cap | $30.7M | ||
Enterprise Value | $20.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$12.3M | ||
Free Cash Flow | -$6.0M | ||
EBIT | -$12.3M | ||
EBITDA | -$12.3M | ||
Net Working Capital | $14.1M | ||
EPS | -$1.51 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 08/25/2025 | ||
Earnings & Revenue